Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection.

Lauring AS, Lee TH, Martin JN, Hunt PW, Deeks SG, Busch M.

PLoS One. 2012;7(11):e50486. doi: 10.1371/journal.pone.0050486. Epub 2012 Nov 29.

2.

Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation.

Cossarizza A, Pinti M, Nasi M, Gibellini L, Manzini S, Roat E, De Biasi S, Bertoncelli L, Montagna JP, Bisi L, Manzini L, Trenti T, Borghi V, Mussini C.

Mitochondrion. 2011 Sep;11(5):750-5. doi: 10.1016/j.mito.2011.06.005. Epub 2011 Jun 23.

PMID:
21722755
3.

Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.

Miura T, Goto M, Hosoya N, Odawara T, Kitamura Y, Nakamura T, Iwamoto A.

J Med Virol. 2003 Aug;70(4):497-505.

PMID:
12794710
4.

Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.

Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D.

J Infect Dis. 2008 Nov 15;198(10):1474-81. doi: 10.1086/592713.

PMID:
18851688
5.

Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.

Morén C, Noguera-Julian A, Rovira N, Garrabou G, Nicolàs M, Cardellach F, Martínez E, Sánchez E, Miró O, Fortuny C.

Antivir Ther. 2011;16(5):719-24. doi: 10.3851/IMP1806.

PMID:
21817193
6.

Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion.

McComsey G, Bai RK, Maa JF, Seekins D, Wong LJ.

J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):181-8.

PMID:
15905734
7.

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

Côté HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JS.

N Engl J Med. 2002 Mar 14;346(11):811-20.

8.

Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Chan JW, Harrigan PR, O'Shaughnessy MV.

J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S85-90. Review.

PMID:
14562863
9.

Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.

Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN.

HIV Med. 2006 Jan;7(1):53-8.

10.

Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.

Martin GE, Gouillou M, Hearps AC, Angelovich TA, Cheng AC, Lynch F, Cheng WJ, Paukovics G, Palmer CS, Novak RM, Jaworowski A, Landay AL, Crowe SM.

PLoS One. 2013;8(1):e55279. doi: 10.1371/journal.pone.0055279. Epub 2013 Jan 24.

11.

Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy.

Kim MJ, Jardel C, Barthélémy C, Jan V, Bastard JP, Fillaut-Chapin S, Houry S, Capeau J, Lombès A.

Antimicrob Agents Chemother. 2008 May;52(5):1670-6. doi: 10.1128/AAC.01449-07. Epub 2008 Mar 10.

12.

Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNA.

Montaner JS, Côté HC, Harris M, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV.

Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S73-9.

PMID:
14986278
13.

Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy.

Cossarizza A, Riva A, Pinti M, Ammannato S, Fedeli P, Mussini C, Esposito R, Galli M.

Antivir Ther. 2003 Aug;8(4):315-21.

PMID:
14518701
14.

Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.

Martin AM, Hammond E, Nolan D, Pace C, Den Boer M, Taylor L, Moore H, Martinez OP, Christiansen FT, Mallal S.

Am J Hum Genet. 2003 Mar;72(3):549-60. Epub 2003 Feb 13. Erratum in: Am J Hum Genet. 2003 May;72(5):1358.

15.

Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.

Hernàndez S, Morén C, López M, Coll O, Cardellach F, Gratacós E, Miró O, Garrabou G.

AIDS. 2012 Feb 20;26(4):419-28. doi: 10.1097/QAD.0b013e32834f3232.

PMID:
22156962
16.

Blood mitochondrial DNA mutations in HIV-infected women and their infants exposed to HAART during pregnancy.

Jitratkosol MH, Sattha B, Maan EJ, Gadawski I, Harrigan PR, Forbes JC, Alimenti A, van Schalkwyk J, Money DM, Côté HC; CIHR Emerging Team Grant on HIV Therapy and Aging (CARMA).

AIDS. 2012 Mar 27;26(6):675-83. doi: 10.1097/QAD.0b013e32835142eb.

PMID:
22436539
17.

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S.

AIDS. 2003 Jun 13;17(9):1329-38.

PMID:
12799554
18.

Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.

Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, Cecchetto MG, Carmona F, De Rossi A.

J Clin Virol. 2012 Mar;53(3):195-200. doi: 10.1016/j.jcv.2011.12.013. Epub 2011 Dec 30.

PMID:
22209290
19.

Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers.

Poirier MC, Divi RL, Al-Harthi L, Olivero OA, Nguyen V, Walker B, Landay AL, Walker VE, Charurat M, Blattner WA; Women and Infants Transmission Study (WITS) Group.

J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):175-83.

PMID:
12794551
20.

Pure Mitochondrial DNA Does Not Activate Human Neutrophils in vitro.

Prikhodko AS, Shabanov AK, Zinovkina LA, Popova EN, Aznauryan MA, Lanina NO, Vitushkina MV, Zinovkin RA.

Biochemistry (Mosc). 2015 May;80(5):629-35. doi: 10.1134/S0006297915050168.

Supplemental Content

Support Center